Open AccessMulticenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region
Author(s) -
Wenbin Wei,
Youxin Chen,
BinJie Hu,
Mingwei Zhao,
Mei Lan K. Han,
Hong Dai,
Harvey S. Uy,
Michelle Y. Chen,
Kate Wang,
Jenny Jiao,
Jean Lou,
Xiaoyan Li
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s325618
Subject(s) - medicine , visual acuity , ophthalmology , dexamethasone , diabetic macular edema , clinical endpoint , macular edema , intraocular pressure , implant , adverse effect , randomized controlled trial , retinal , clinical trial , diabetic retinopathy , surgery , diabetes mellitus , endocrinology
To evaluate the safety and efficacy of dexamethasone intravitreal implant 0.7 mg (DEX) compared with laser photocoagulation in patients with diabetic macular edema (DME).